Skip to main content
. 2019 Oct 31;10(4):10.24926/iip.v10i4.1660. doi: 10.24926/iip.v10i4.1660

Exhibit 3. MHRA (2007) in the context of extemporaneous preparation [14].

  • Extemporaneously prepared medicines should be formulated and prepared in compliance with current legal requirements and standards.

  • Preparation and quality control arrangements are to be documented and in compliance with current GPP requirements.

  • All products prepared should be quality suitable for their intended use

  • Products are released for patient use only by a pharmacist.

  • Documentation and records should comply recommendations in this guidance document.